Kidney Stones

Williams Textbook of Endocrinology, Twelfth Edition

Volumn , Issue , 2011, Pages 1350-1367

  Monk, Rebeca D ^a   Bushinsky, David A ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85170195662     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4377-0324-5.00030-4     Document Type: Chapter

References (152)

1. KK Stamatelou, ME Francis, CA Jones, et al. (2003) Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int 63 1817-1823.
2. RD Monk (1996) Clinical approach to adults. Semin Nephrol 16 375-388.
3. Consensus Conference (1988) Prevention and treatment of kidney stones. JAMA 260 977-981.
4. RD Monk and DA Bushinsky (2007) Nephrolithiasis and nephrocalcinosis. J Frehally, J Floege, RJ Johnson,(Eds) Comprehensive Clinical Nephrology London, UK: Mosby 641-655.
5. DA Bushinsky, FL Coe and OW Moe (2008) Nephrolithiasis. BM Brenner,(Eds) The Kidney Philadelphia, PA: WB Saunders 1299-1349.
6. DL Gillen, EM Worcester and FL Coe (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kid Int 67 685-690.
7. AD Rule, EJ Bergstralh, LJ Melton III, et al. (2009) Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol 4 804-811.
8. N Chen, W Wang, Y Huang, et al. (2009) Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 24 2117-2123.
9. N Stankus, M Hammes, D Gillen, et al. (2007) African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35 83-87.
10. K Sakhaee (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17 304-309.
11. NS Anavekar, JJ McMurray, EJ Velazquez, et al. (2004) Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 1285-1295.
12. AS Go, GM Chertow, D Fan, et al. (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 1296-1305.
13. DE Weiner, H Tighiouart, MG Amin, et al. (2004) Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 1307-1315.
14. JM Soucie, MJ Thun, RJ Coates, et al. (1994) Demographic and geographic variability of kidney stones in the United States. Kidney Int 46 893-899.
15. OW Moe (2006) Kidney stones: pathophysiology and medical management. Lancet 367 333-344.
16. JM Soucie, RJ Coates, W McClellan, et al. (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143 487-495.
17. NM Maalouf, MA Cameron, OW Moe, et al. (2004) Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens 13 181-189.
18. N Mandel (1996) Mechanism of stone formation. Semin Nephrol 16 364-374.
19. AK Hau, TH Kwan and PK Li (2009) Melamine toxicity and the kidney. J Am Soc Nephrol 20 245-250.
20. V Bhalla, PC Grimm, GM Chertow, et al. (2009) Melamine nephrotoxicity: an emerging epidemic in an era of globalization. Kidney Int 75 774-779.
21. N Guan, Q Fan, J Ding, et al. (2009) Melamine-contaminated powdered formula and urolithiasis in young children. N Engl J Med 360 1067-1074.
22. AP Evan, JE Lingeman, FL Coe, et al. (2003) Randall plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111 607-616.
23. FL Coe, A Evan and E Worcester (2005) Kidney stone disease. J Clin Invest 115 2598-2608.
24. JA Sayer, G Carr and NL Simmons (2004) Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci 106 549-561.
25. DA Bushinsky (2000) Renal lithiasis. HD Humes,(Eds) Kelly's Textbook of Medicine New York, NY: Lippincott Williams & Wilkens 1243-1248.
26. L Borghi, T Meschi, F Amato, et al. (1996) Urinary volume, water, and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155 839-843.
27. J Lemann Jr, JA Pleuss, EA Worcester, et al. (1996) Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int 49 200-208. [Erratum: Kidney Int 50:341,1996.]
28. DH Hosking, SB Erickson, CJ Van Den Berg, et al. (1983) The stone clinic effect in patients with idiopathic calcium urolithiasis. J Urol 130 1115-1118.
29. FP Muldowney, R Freaney and MF Moloney (1972) Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 22 292-296.
30. J Lemann Jr, EA Worcester and RW Gray (1991) Hypercalciuria and stones. Finlayson Colloquium on Urolithiasis. Am J Kidney Dis 17 386-391.
31. L Borghi, T Schianchi, T Meschi, et al. (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Eng J Med 346 77-84.
32. J Lemann Jr, DA Bushinsky and LL Hamm (2003) Bone buffering of acid and base in humans. Am J Physiol Renal Physiol 285 F811-F832.
33. DA Bushinsky (2004) Acid-base balance and bone health. MF Holick, B Dawson-Hughes,(Eds) Nutrition and Bone Health Totowa, NJ: Humana 279-304.
34. LL Hamm (1990) Renal handling of citrate. Kidney Int 38 728-735.
35. P Bataille, JM Achard, A Fournier, et al. (1991) Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers. Kidney Int 39 1193-1205.
36. EN Taylor and GC Curhan (2007) Fructose consumption and the risk of kidney stones. Kidney Int 73 207-212.
37. GC Curhan, WC Willett, EB Rimm, et al. (1993) A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328 833-838.
38. DA Bushinsky (2002) Recurrent hypercalciuric nephrolithiasis: does diet help? N Eng J Med 346 124-125.
39. FL Coe, MJ Favus, T Crockett, et al. (1982) Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 72 25-32.
40. M Freundlich, E Alonzo, E Bellorin-Font, et al. (2002) Reduced bone mass in children with idiopathic hypercalciuria and in their asymptomatic mothers. Nephrol Dial Transplant 17 1396-1401.
41. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board and Institute of Medicine (1997) Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press
42. RD Jackson, AZ LaCroix, M Gass, et al. (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354 669-683.
43. OW Moe and O Bonny (2005) Genetic hypercalciuria. J Am Soc Nephrol 16 729-745.
44. RD Monk, DA Bushinsky (1996) Pathogenesis of idiopathic hypercalciuria. F Coe, M Favus, C Pak, et al., (Eds) Kidney Stones: Medical and Surgical Management Philadelphia, PA: Lippincott-Raven 759-772.
45. DA Bushinsky and RD Monk (1998) Calcium. Lancet 352 306-311.
46. J Lemann Jr (1992) Pathogenesis of idiopathic hypercalciuria and nephrolithiasis. FL Coe, MJ Favus,(Eds) Disorders of Bone and Mineral Metabolism New York, NY: Raven Press, Ltd. 685-706.
47. FL Coe, MJ Favus and JR Asplin (2004) Nephrolithiasis. BM Brenner, FC Rector, Jr,(Eds) The Kidney Philadelphia, PA: WB Saunders 1819-1866.
48. RA Kaplan, MR Haussler, LJ Deftos, et al. (1977) The role of 1,25 dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 59 756-760.
49. JR Asplin, KA Bauer, J Kinder, et al. (2003) Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int 63 662-669.
50. CYC Pak, CV Odvina, MS Pearle, et al. (2005) Effect of dietary modification on urinary stone risk factors. Kidney Int 68 2264-2273.
51. CYC Pak, M Ohata, EC Lawrence, et al. (1974) The hypercalciurias: causes, parathyroid functions, and diagnostic criteria. J Clin Invest 54 387-400.
52. J Yao, AJ Karnauskas, DA Bushinsky, et al. (2005) Regulation of renal calcium-sensing receptor gene expression in response to 1,25(OH)2D3 in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16 1300-1308.
53. DA Bushinsky and JR Asplin (2005) Thiazides reduce brushite, but not calcium oxalate, supersaturation and stone formation in genetic hypercalciuric stone-forming rats. J Am Soc Nephrol 16 417-424.
54. DA Bushinsky, KK Frick and K Nehrke (2006) Genetic hypercalciuric stone-forming rats. Curr Opinion Nephrol Hyperten 15 403-418.
55. DA Bushinsky, WR Parker and JR Asplin (2000) Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 57 550-560.
56. DA Bushinsky, JR Asplin, MD Grynpas, et al. (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61 975-987.
57. RR Hoopes Jr, FA Middleton, S Sen, et al. (2006) Isolation and confirmation of a calcium excretion quantitative trait locus on chromosome 1 in genetic hypercalciuric stone-forming congenic rats. J Am Soc Nephrol 17 1292-1304.
58. DA Bushinsky and MJ Favus (1988) Mechanism of hypercalciuria in genetic hypercalciuric rats: inherited defect in intestinal calcium transport. J Clin Invest 82 1585-1591.
59. M Kim, NE Sessler, V Tembe, et al. (1993) Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 43 189-196.
60. CY Pak (1997) Nephrolithiasis. Current Ther Endo Metab 6 572-576.
61. NS Krieger, VM Stathopoulos and DA Bushinsky (1996) Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Am J Physiol (Cell Physiol) 271 C130-C135.
62. M Grynpas, S Waldman, D Holmyard, et al. (2009) Genetic hypercaliuric stone-forming rats have a primary decrease in bone mineral density and strength. J Bone Miner Res 24 1420-1426.
63. DA Bushinsky, KJ Neumann, J Asplin, et al. (1999) Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 55 234-243.
64. S Tsuruoka, DA Bushinsky and GJ Schwartz (1997) Defective renal calcium reabsorption in genetic hypercalciuric rats. Kidney Int 51 1540-1547.
65. AJ Karnauskas, JP van Leeuwen, GJ van den Bemd, et al. (2005) Mechanism and function of high vitamin D receptor levels in genetic hypercalciuric stone-forming rats. J Bone Min Res 20 447-454.
66. X-Q Li, V Tembe, GM Horwitz, et al. (1993) Increased intestinal vitamin D receptor in genetic hypercalciuric rats: a cause of intestinal calcium hyperabsorption. J Clin Invest 91 661-667.
67. MJ Favus, AJ Karnauskas, JH Parks, et al. (2004) Peripheral blood monocyte vitamin D receptor levels are elevated in patients with idiopathic hypercalciuria. J Clin Endocrinol Metab 89 4937-4943.
68. G Gambaro, G Vezzoli, G Casari, et al. (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44 963-986.
69. G Thorleifsson, H Holm, V Edvardsson, et al. (2009) Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nat Genet 41 926-930.
70. SJ Scheinman, LM Guay-Woodford, RV Thakker, et al. (1999) Genetic disorders of renal electrolyte transport. N Engl J Med 340 1177-1187.
71. SE Lloyd, SH Pearce, SE Fisher, et al. (1996) A common molecular basis for three inherited kidney stone diseases. Nature 379 445-449.
72. KK Frick and DA Bushinsky (2003) Molecular mechanisms of primary hypercalciuria. J Am Soc Nephrol 14 1082-1095.
73. M Naesens, P Steels, R Verberckmoes, et al. (2004) Bartter's and Gitelmans' syndromes: from gene to clinic. Nephron Phys 96 65-78.
74. J Hou, A Renigunta, AS Gomes, et al. (2009) Claudin-16 and claudin-19 interaction is required for their assembly into tight junctions and for renal reabsorption of magnesium. Proc Natl Acad Sci U S A 106 15350-15355.
75. J Hou, A Renigunta, M Konrad, et al. (2008) Claudin-16 and claudin-19 interact and form a cation-selective tight junction complex. J Clin Invest 118 619-628.
76. JA Nicoletta and GJ Schwartz (2004) Distal renal tubular acidosis. Current Opin Pediatr 16 194-198.
77. C Bergwitz, NM Roslin, M Tieder, et al. (2006) SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis. Am J Hum Genet 78 179-192.
78. M Levi, J Blaine, S Breusegem, et al. (2006) Renal phosphate-wasting disorders. Adv Chron Kidney Dis 13 155-165.
79. JMH Teichman (2004) Acute renal colic from ureteral calculus. N Engl J Med 350 684-693.
80. DS Milliner (2005) The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol 25 154-160.
81. K Sakhaee (1996) Pathogenesis and medical management of cystinuria. Semin Nephrol 16 435-447.
82. CJ Danpure (2005) Molecular etiology of primary hyperoxaluria type 1: new direction for treatment. Am J Nephrol 25 303-310.
83. K Nehrke, J Arreola, HV Nguyen, et al. (2002) Loss of hyperpolarization-activated Cl − current in salivary acinar cells from Clcn2 knockout mice. J Biol Chem 277 23604-23611.
84. C Gimpel, A Krause, P Franck, et al. (2009) Exposure to furosemide as the strongest risk factor for nephrocalcinosis in preterm infants. Pediatr Int 52 51-56.
85. EA Schell-Feith, JE Kist-van Holthe, N Conneman, et al. (2000) Etiology of nephrocalcinosis in preterm neonates: association of nutritional intake and urinary parameters. Kidney Int 58 2102-2110.
86. M Daudon and P Jungers (2004) Drug-induced renal calculi: epidemiology, prevention and management. Drugs 64 245-275.
87. EN Taylor and GC Curhan (2008) Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol 3 1453-1460.
88. JS Rodman (1999) Struvite stones. Nephron 81(suppl 1), 50-59.
89. GS Mandel, N Mandel (1996) Analysis of stones. FL Coe, MJ Favus, CYC Pak, et al., (Eds) Kidney Stones: Medical and Surgical Management Philadelphia, PA: Lippincott-Raven 323-335.
90. ER Denton, A Mackenzie, T Greenwell, et al. (1999) Unenhanced helical CT for renal colic: is the radiation dose justifiable? Clin Radiol 54 444-447.
91. RC Smith and DM Coll (2000) Helical computed tomography in the diagonosis of ureteric colic. BJU Int 86(suppl 1), 33-41.
92. SY Nakada, DG Hoff, S Attai, et al. (2000) Determination of stone composition by noncontrast spiral computed tomography in the clinical setting. Urology 55 816-819.
93. JH Parks, M Coward and FL Coe (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51 894-900.
94. GM Preminger, HG Tiselius, DG Assimos, et al. (2007) 2007 Guideline for the management of ureteral calculi. J Urol 178 2418-2434.
95. M Sofer, JD Watterson, TA Wollin, et al. (2002) Holmium:YAG laser lithotripsy for upper urinary tract calculi in 598 patients. J Urol 167 31-34.
96. GR Wignall, BK Canales, JD Denstedt, et al. (2008) Minimally invasive approaches to upper urinary tract urolithiasis. Urol Clin North Am 35 441-454. viii
97. MK Samplaski, BH Irwin and M Desai (2009) Less-invasive ways to remove stones from the kidneys and ureters. Cleve Clin J Med 76 592-598.
98. SS Putman, BD Hamilton and DB Johnson (2004) The use of shock wave lithotripsy for renal calculi. Curr Opin Urol 14 117-121.
99. RJ Leveillee and L Lobik (2003) Intracorporeal lithotripsy: which modality is best? Curr Opin Urol 13 249-253.
100. MA Beach and LS Mauro (2006) Pharmacologic expulsive treatment of ureteral calculi. Ann Pharmacother 40 1361-1368.
101. L Borghi, T Meschi, F Amato, et al. (1994) Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 152 1095-1098.
102. F Porpiglia, G Ghignone, C Fiori, et al. (2004) Nifedipine versus tamsulosin for the management of lower ureteral stones. J Urol 172 568-571.
103. M Dellabella, G Milanese and G Muzzonigro (2005) Randomized trial of the efficacy of tamsulosin, nifedipine and phloroglucinol in medical expulsive therapy for distal ureteral calculi. J Urol 174 167-172.
104. J Uribarri, MS Oh and HJ Carroll (1989) The first kidney stone. Kidney Int 111 1006-1009.
105. T Meschi, T Schianchi, E Ridolo, et al. (2004) Body weight, diet and water intake in preventing stone disease. Urol Int 72 29-33.
106. T Meschi, U Maggiore, E Fiaccadori, et al. (2004) The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 66 2402-2410.
107. GC Curhan, WC Willett, FE Speizer, et al. (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126 497-504.
108. FL Coe, JH Parks, DA Bushinsky, et al. (1988) Chlorthalidone promotes mineral retention in patients with idiopathic hypercalciuria. Kidney Int 33 1140-1146.
109. L Borghi, T Meschi, A Guerra, et al. (1993) Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol. 22(suppl 6), S78-S86.
110. CYC Pak, C Fuller, K Sakhaee, et al. (1985) Long-term treatment of calcium oxalate nephrolithiasis with potassium citrate. J Urol 134 11-19.
111. M Hatch and RW Freel (2005) Intestinal transport of an obdurate anion: oxalate. Urol Res 33 1-16.
112. P Jaeger and WG Robertson (2004) Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Phys 98 64-71.
113. RP Holmes, HO Goodman and DG Assimos (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kid Int 59 270-276.
114. JH Parks, EM Worcester, RC O'Connor, et al. (2003) Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kid Int 63 255-265.
115. CW McIntyre (2008) Calcium balance during hemodialysis. Semin Dial 21 38-42.
116. DE Barilla, C Notz, D Kennedy, et al. (1978) Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias: effect of calcium and magnesium. Am J Med 64 579-585.
117. M Hatch, RW Freel, AM Goldner, et al. (1983) Comparison of effects of low concentrations of ricinoleate and taurochenodeoxycholate on colonic oxalate and chloride absorption. Gastroenterology 84 1181.
118. M Hatch, RW Freel, AM Goldner, et al. (1981) Effect of bile salt on active oxalste transport in the colon. H Kasper, H Goebell,(Eds) Colon and Nutrition Lancaster, England: MTP 299-305.
119. B Nordenvall, L Backman, L Larsson, et al. (1983) Effects of calcium, aluminum, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass. Acta Chir Scand 149 93-98.
120. AM Clarke and RG McKenzie (1969) Ileostomy and the risk of urinary uric acid stones. Lancet 2 395-397.
121. D Rudman, JL Dedonis, MT Fountain, et al. (1980) Hypocituria in patients with gastrointestinal malabsorption. N Engl J Med 303 657-661.
122. EM Worcester (1996) Stones due to bowel disease. FL Coe, MJ Favus, CYC Pak, et al., (Eds) Kidney Stones: Medical and Surgical Management Philadelphia, PA: Lippincott-Raven 883-903.
123. M Petrarulo, C Vitale, P Facchini, et al. (1998) Biochemical approach to diagnosis and differentiation of primary hyperoxalurias: an update. J Nephrol 11 23-28.
124. C Kwak, HK Kim, EC Kim, et al. (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44 475-481.
125. RWE Watts, CJ Danpure, L de Pauw, et al. (1991) Combined liver-kidney and isolated liver transplantations for primary hyperoxaluria type 1: the European experience. Nephrolol Dial Transplant 6 502-511.
126. FL Coe, JH Parks and JR Asplin (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327 1141-1152.
127. S Millman, AL Strauss, JH Parks, et al. (1982) Pathogenesis and clinical course of mixed calcium oxalate and uric acid nephrolithiasis. Kidney Int 22 366-370.
128. F Grases, P Sanchis, B Isern, et al. (2007) Uric acid as inducer of calcium oxalate crystal development. Scand J Urol Nephrol 41 26-31.
129. CY Pak and LH Arnold (1975) Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med 149 930-932.
130. PK Grover, VR Marshall and RL Ryall (2003) Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis. Chem Biol 10 271-278.
131. PK Grover, RL Ryall and VR Marshall (1993) Dissolved urate promotes calcium oxalate crystallization: epitaxy is not the cause. Clin Sci (Lond) 85 303-307.
132. PK Grover and RL Ryall (2007) Allopurinol for stones: right drug—wrong reasons. Am J Med 120 380.
133. FL Coe (1977) Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder. Ann Int Med 87 404-410.
134. JE Zerwekh, K Holt and CY Pak (1983) Natural urinary macromolecular inhibitors: attenuation of inhibitory activity by urate salts. Kidney Int 23 838-841.
135. PK Grover, RL Ryall and VR Marshall (1992) Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans. Kid Int 41 149-154.
136. RL Ryall, CM Hibberd and VR Marshall (1986) The effect of crystalline monosodium urate on the crystallization of calcium oxalate in whole human urine. Urol Res 14 63-65.
137. CY Pak (1987) Citrate and renal calculi. Miner Electrolyte Metab 13 257-266.
138. CYC Pak and C Fuller (1986) Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med 104 33-37.
139. P Ramchandani, HM Pollack (1996) Radiologic evaluation of patients with urolithiasis. FL Coe, MJ Favus, CYC Pak, et al., (Eds) Kidney Stones: Medical and Surigical Management Philadelphia, PA: Lippincott-Raven 369-435.
140. NM Maalouf, K Sakhaee, JH Parks, et al. (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65 1422-1425.
141. K Sakhaee, B Adams-Huet, OW Moe, et al. (2002) Pathyophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int 62 971-979.
142. B Ettinger, A Tang, JT Citron, et al. (1986) Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 315 1386-1389.
143. HY Wong, CR Riedl and DP Griffith (1996) Medical management and prevention of struvite stones. FL Coe, MJ Favus, CYC Pak,(Eds) Kidney Stones: Medical and Surgical Management Philadelphia, PA: Lippincott-Raven 941-950.
144. EK Michaels (1966) Surgical management of struvite stones. FL Coe, MJ Favus, CYC Pak, et al., (Eds) Kidney Stones: Medical and Surgical Management Philadelphia, PA: Lippincott-Raven 951-970.
145. NO Bernardo and AD Smith (2000) Chemolysis of urinary calculi. Urol Clin North Am 27 355-365.
146. DP Griffith, PA Moskowitz and CE Carlton Jr (1979) Adjunctive chemotherapy of infection-induced staghorn calculi. J Urol 121 711-715.
147. DE Silverman and TA Stamey (1983) Management of infection stones: the Stanford experience. Medicine (Baltimore) 62 44-51.
148. GR Sant and JG Blaivas (1983) Hemiacidrin irrigation in the management of struvite calculi: long-term results. J Urol 130 1048-1050.
149. M Font-Llitjos, M Jimenez-Vidal, L Bisceglia, et al. (2005) New insights into cystinuria: 40 new mutations, genotype-phenotype correlation, and digenic inheritance causing partial phenotype. J Med Genet 42 58-68.
150. FO Kolb, JM Earll and HA Harper (1967) “Disappearance” of cystinuria in a patient treated with prolonged low methionine diet. Metabolism 16 378-381.
151. CYC Pak (1987) Prevention of recurrent nephrolithiasis. CYC Pak,(Eds) Renal Stone Disease: Pathogenesis, Prevention, and Treatment Boston, MA: Martinus-Njhoff 165-199.
152. CYC Pak (1990) Cystine lithiasis. MI Resnick, CYC Pak,(Eds) Urolithiasis: A Medical and Surgical Reference Philadelphia, PA: WB Saunders 133-143.